Clinical Trials Browser

Leukemia, Plasma Cell × Budesonide × Plasma cell × Clear all

NCT05405387 2025-12-03

IMPACT

Phase 2 Suspended

Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell, Multiple Myeloma